In summary, our findings establish ADGRG6 as a multifaceted oncogenic regulator in PAAD that promotes tumor progression through both cell-autonomous mechanisms and potential immune-associated pathways. Here, ADGRG6 is linked to pancreatic adenocarcinoma.